跳至主要内容
临床试验/DRKS00024360
DRKS00024360招募中未知

In vivo evaluation of molecular tissue properties of enthesial structures using multispectral optoacoustic tomography (MSOT) and arthrosonography in patients with inflammatory joint diseases (psoriasis, psoriatic arthritis) (MAPSA). - MAPSA

niversitätsklinikum Erlangen0 个研究点目标入组 90 人开始时间: 2021年2月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Adult male or female patients capable of giving consent
  • - Age 18 - 80 years
  • - Present informed consent to participate in the study.
  • - Group 1 PsA
  • o Diagnosis of PsO (clinical and/or histological)
  • o Diagnosis of PsA according to CASPAR criteria
  • - Group 2 PsO
  • o Diagnosis of PsO (clinical and/or histological)

排除标准

  • - Pregnancy
  • - Heavy physical activity
  • - Other previous musculoskeletal disease (such as rheumatoid arthritis, osteoarthritis)
  • - Tumor disease, diabetes mellitus, cardiovascular disease, chronic kidney, gastrointestinal, or liver disease
  • - Group 1 PsA
  • o Pre-treatment or ongoing therapy with bDMARD and/or tsDMARD.
  • - Group 2 PsO
  • o Diagnosis/family history of rheumatic disease.
  • o tendon pain, joint swelling
  • o Pre-treatment or ongoing therapy with bDMARD and/or tsDMARD.
  • - Group 3 Healthy individuals
  • o diagnosis/family history of rheumatic disease
  • o Diagnosis of PsO/PsA
  • o tendon pain, joint swelling

研究者

发起方
niversitätsklinikum Erlangen

相似试验